A- A A+

Frequency of Potential Drug-Drug Interactions in the Changing Field of HCV Therapy.

Schulte B, Wübbolding M, Marra F, Port K, Manns MP, Back D, Cornberg M, Stichtenoth DO, Höner Zu Siederdissen C, Maasoumy B.

Open Forum Infect Dis. 2020 Feb 3;7(2):ofaa040. doi: 10.1093/ofid/ofaa040.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033915/